Category: Emerging Medicine
One of the several noteworthy trials presented at the virtual ESC Congress was the EAST-AFNET 4NET 4 trial, which was published concurrently in the New England Journal of Medicine.
A group of Italian researchers recently hypothesized that it is actually the endothelium that is being targeted by the COVID-19 virus.
COVID-19 does not always fit into the pattern of respiratory illness. While initially unexpected, clinicians and researchers are learning more each day that COVID-19 infection wears many disguises. In some victims, it clearly does not make its initial appearance as a respiratory virus.
Atrial Fibrillation: Scope of the Problem The prevalence of atrial fibrillation (AF) in the United States is estimated to rise from ≈5.2 million in 2010 to 12.1 million in 2030.…
Partnering with patients to assess their risk for cardiovascular disease can be a challenge. Developing a plan of care to manage hypertension is individualized; incorporating patient buy-in sets the stage…
The 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease includes management of diabetes mellitus as a key takeaway for cardiologists caring for patients with this comorbidity.
Challenge your knowledge of this patient population with K2P and Dr. Biykem Bozkurt, MD, PhD’s series on evidence-based management of heart failure.
The relationship between diabetes and cardiovascular disease are interdependent, requiring a deep understanding of the management of diabetes mellitus.
A December 18, 2019 case report in JACC underscores the complex and varied challenges for patients with a paravalvular leak.
DeVore and colleagues’ (JAMA Cardiology, Dec 11) secondary analysis of the open-label extension of the PIONEER-HF examined the effect of switching from taking enalapril (10 mg twice daily) to sacubitril/valsartan…